ATLASVanguard Russell 3000 ETF (VTHR): outlook, holdings and fees
Vanguard Russell 3000 ETF (VTHR) is an exchange-traded fund and is managed by Vanguard. The expense ratio is 0.09% and the yield is 0.98%. The ten largest holdings are 34% of the fund.
Fund data as of Oct 14, 2026 · Price Nov 2, 2026
ATLAS view on VTHR
| Last price | $332.77 (-1.8%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 56% |
| Likely 1-month range (50%) | $326.75 – $342.36 |
| Normal 1-day range (±1σ) | ±0.8% |
| Distribution yield | 0.98% |
ATLAS probabilities use the same calibrated model as every stock page. A fair value is shown for companies, not funds; the holdings below link to the fair value of each company.
VTHR fund facts
| Issuer | Vanguard |
|---|---|
| Theme | Other strategies |
| Assets under management | $5.0B |
| Expense ratio | 0.09% |
| Number of holdings | 50 |
| Portfolio turnover | 12% |
| Inception | Sep 20, 2010 |
| Exchange | NASDAQ |
The advisor employs an indexing investment approach designed to track the performance of the Russell 3000® Index, which represents approximately 98% of the U.S. equity market and comprises the 3,000 largest companies in the United States. The Advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index. The fund is non-diversified.
VTHR top holdings
| Holding | Sector | Weight |
|---|---|---|
| NVIDIA Corporation NVDA | Technology | 7.27% |
| Apple Inc. AAPL | Technology | 6.27% |
| Microsoft Corporation MSFT | Technology | 5.26% |
| Amazon.com Inc AMZN | Consumer Cyclical | 3.25% |
| Alphabet Inc Class A GOOGL | Communication Services | 2.75% |
| Broadcom Inc AVGO | Technology | 2.25% |
| Alphabet Inc Class C GOOG | Communication Services | 2.07% |
| Meta Platforms Inc. META | Communication Services | 1.77% |
| Micron Technology Inc MU | Technology | 1.52% |
| Tesla Inc TSLA | Consumer Cyclical | 1.45% |
Holdings with an ATLAS page link to their probability range, fair value and earnings calendar.
VTHR sector breakdown
| Sector | Weight |
|---|---|
| Technology | 36.8% |
| Financial Services | 12.3% |
| Consumer Cyclicals | 9.8% |
| Healthcare | 9.6% |
| Communication Services | 9.0% |
| Industrials | 8.6% |
| Consumer Defensive | 4.1% |
| Energy | 3.6% |
| Real Estate | 2.2% |
| Basic Materials | 2.1% |
| Utilities | 2.0% |
By region: North America 99.3%, Europe Developed 0.3%, Latin America 0.2%.
VTHR returns and risk
| Year to date | +14.2% |
|---|---|
| 1 year | +16.1% |
| 3 years (annualised) | +21.9% |
| 5 years (annualised) | +13.1% |
| 10 years (annualised) | +15.6% |
| Volatility (3 years) | 13.1% |
| Sharpe ratio (3 years) | 1.25 |
Past returns do not guarantee future results.
VTHR: frequently asked questions
What does VTHR invest in?
Vanguard Russell 3000 ETF invests in a portfolio of securities. Its largest holdings are NVIDIA Corporation (7.3%), Apple Inc. (6.3%), Microsoft Corporation (5.3%), Amazon.com Inc (3.2%), Alphabet Inc Class A (2.7%).
What is the VTHR expense ratio?
0.09% a year: about $9.00 for every $10,000 invested.
What is the VTHR dividend yield?
0.98%. ATLAS does not hold the exact distribution dates for ETFs.
Will VTHR go up?
Nobody can know. The ATLAS model puts the chance of a higher price in one month at 56%, with a likely range (50%) of $326.75 to $342.36 from $332.77 today. It is a probability, not a prediction.
How has VTHR performed?
Year to date +14.2%, one year +16.1%, three years +21.9% a year, five years +13.1% a year. Past returns do not guarantee future results.
Similar ETFs: Other strategies
- iShares Russell 1000 ETF (IWB)
- Vanguard Extended Market ETF (VXF)
- State Street SPDR S&P MidCap 400 ETF Trust (MDY)
- iShares S&P 100 ETF (OEF)
- iShares Russell 3000 ETF (IWV)
- Vanguard Mortgage-Backed Securities ETF (VMBS)
- State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF (SPTM)
- iShares Preferred and Income Securities ETF (PFF)
Educational information, not investment advice. Disclaimer